Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11297816rdf:typepubmed:Citationlld:pubmed
pubmed-article:11297816lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:11297816lifeskim:mentionsumls-concept:C0022614lld:lifeskim
pubmed-article:11297816lifeskim:mentionsumls-concept:C0080093lld:lifeskim
pubmed-article:11297816lifeskim:mentionsumls-concept:C0008300lld:lifeskim
pubmed-article:11297816lifeskim:mentionsumls-concept:C0034746lld:lifeskim
pubmed-article:11297816lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:11297816lifeskim:mentionsumls-concept:C0700301lld:lifeskim
pubmed-article:11297816lifeskim:mentionsumls-concept:C0021420lld:lifeskim
pubmed-article:11297816pubmed:issue1lld:pubmed
pubmed-article:11297816pubmed:dateCreated2001-4-12lld:pubmed
pubmed-article:11297816pubmed:abstractTextKetamine is an N-methyl-D-aspartate antagonist that induces cognitive dysfunctions. The purpose of the present study was to investigate the effects of a subanesthetic dose of ketamine on human information processing, using the additive factor method. During perfusion of a subanesthetic dose of ketamine (0.5 mg/kg over 60 min) or a placebo (randomized double-blind, cross-over design), eight adults (aged 22-33, mean=27) performed a two-choice visual reaction time (RT) task. Signal intensity, stimulus-response mapping, and foreperiod duration were manipulated. The effects of these three variables were found to be additive on RT, indicating that three independent stages - namely, stimulus preprocessing, response selection and motor selection- were manipulated. Ketamine altered RT performance in a specific way: it interacted with foreperiod duration but its effect was additive with those of signal intensity and stimulus-response mapping. These results show that ketamine specifically affects the stage of motor adjustment, which suggests that the glutamatergic system plays an important role in motor processes.lld:pubmed
pubmed-article:11297816pubmed:languageenglld:pubmed
pubmed-article:11297816pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11297816pubmed:citationSubsetIMlld:pubmed
pubmed-article:11297816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11297816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11297816pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11297816pubmed:statusMEDLINElld:pubmed
pubmed-article:11297816pubmed:monthAprlld:pubmed
pubmed-article:11297816pubmed:issn0304-3940lld:pubmed
pubmed-article:11297816pubmed:authorpubmed-author:BlinOOlld:pubmed
pubmed-article:11297816pubmed:authorpubmed-author:MicallefJJlld:pubmed
pubmed-article:11297816pubmed:authorpubmed-author:HasbroucqTTlld:pubmed
pubmed-article:11297816pubmed:authorpubmed-author:GuillermainYYlld:pubmed
pubmed-article:11297816pubmed:authorpubmed-author:PossamaïCClld:pubmed
pubmed-article:11297816pubmed:issnTypePrintlld:pubmed
pubmed-article:11297816pubmed:day27lld:pubmed
pubmed-article:11297816pubmed:volume303lld:pubmed
pubmed-article:11297816pubmed:ownerNLMlld:pubmed
pubmed-article:11297816pubmed:authorsCompleteYlld:pubmed
pubmed-article:11297816pubmed:pagination29-32lld:pubmed
pubmed-article:11297816pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:meshHeadingpubmed-meshheading:11297816...lld:pubmed
pubmed-article:11297816pubmed:year2001lld:pubmed
pubmed-article:11297816pubmed:articleTitleN-methyl-D-aspartate receptors and information processing: human choice reaction time under a subanaesthetic dose of ketamine.lld:pubmed
pubmed-article:11297816pubmed:affiliationCentre de Recherches en Neurosciences Cognitives, Centre National de la Recherche Scientifique, 13402 Marseille Cedex 20, France.lld:pubmed
pubmed-article:11297816pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11297816pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11297816pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:11297816pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11297816lld:pubmed